what amount is microdosing glp 1 GLP-1s, and Is It Safe? What is GLP-1 Microdosing, and

Considered unlikely by most analysts given the shortage resolution and the FDA's stated position, but possible if legal challenges or congressional pressure intervenes

It develops when the body loses more fluids than it takes in, disrupting the normal balance of electrolytes

The first GLP-1 medication (liraglutide) was only approved in 2014, and semaglutide wasnt approved until 2017

The body doesnt feel the need to keep excess weight on to prevent starvation

Treatment-related considerations specific to semaglutide therapy include: Gastrointestinal adverse effects : Persistent nausea, vomiting, or diarrhea leading to inadequate fluid replacement creates a state of relative dehydration

(Susans note) What is an Agonist